Results 241 to 250 of about 912,975 (349)

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.

Clinical Infectious Diseases, 2016
Kathleen N Ly, Elizabeth M Hughes, R. Jiles, S. Holmberg   +3 more
semanticscholar   +1 more source

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.

, 1994
Patrizia Farci, H. J. Alter, D C Wong, R.H. Miller, Sugantha Govindarajan, Ronald E. Engle, Max Shapiro, R H Purcell   +7 more
openalex   +1 more source

Incidence of major cardiovascular events in patients with metabolic dysfunction‐associated steatotic liver disease in the general population

European Journal of Heart Failure, EarlyView.
Aims Major adverse cardiovascular events (MACE) related to cardiovascular disease are a major cause of death in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). We explored the impact of MASLD on incident MACE and overall mortality in the general population in Germany.
Yvonne Huber, Lea Hofmann, Jürgen H. Prochaska, Thomas Koeck, Julian Chalabi, Norbert Pfeiffer, Manfred Beutel, Konstantin Strauch, Karl J. Lackner, Oliver Tüscher, Thomas Münzel, Matthias M. Weber, Julia Weinmann‐Menke, Philipp Wild, Peter R. Galle, Jörn M. Schattenberg   +15 more
wiley   +1 more source

Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity

, 1993
Peter Simmonds, F. McOmish, P.L. Yap, Shiu‐Wan Chan, C. K. Lin, Geoffrey Dusheiko, Ahmed Saeed, Edward C. Holmes   +7 more
openalex   +1 more source

Hepatitis C virus: evidence for sexual transmission. [PDF]

, 1991
Richard S. Tedder, Richard Gilson, Moya Briggs, Clive Loveday, C.H. Cameron, Jeremy A. Garson, Gabrielle E. Kelly, I V Weller   +7 more
openalex   +1 more source

Cost-Effectiveness of Hepatitis C Virus Case Finding and Treatment in Eastern Europe and Central Asia. [PDF]

Liver Int
Walker JG, Schumacher IT, Trickey A, Vickerman P.   +3 more
europepmc   +1 more source

Management and Modification of Flavonoids Against Nonalcoholic Fatty Liver Disease

Food Bioengineering, EarlyView.
Flavonoids protect against NAFLD by enhancing mitochondrial function, reducing ER stress, and modulating gut microbiota. Structural modifications improve flavonoid efficacy, offering a promising dietary strategy for NAFLD management. ABSTRACT Flavonoids are small bioactive molecules commonly found in plant‐derived foods, exhibiting antioxidant, anti ...
Weidong Bai, Bingqi Huang, Wenhong Zhao, Gongliang Liu, Limei Yu, Zhi Lu, Hong Wang   +6 more
wiley   +1 more source

Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants

, 1992
Shiu‐Wan Chan, F. McOmish, Edward C. Holmes, B. C. Dow, J F Peutherer, E. A. C. Follett, P.L. Yap, Peter Simmonds   +7 more
openalex   +1 more source

Detection of Chronic Hepatitis C Virus Infection by Four Diagnostic Systems: First–Generation and Second–Generation Enzyme–Linked Immunosorbent Assay, Second–Generation Recombinant Immunoblot Assay and Nested Polymerase Chain Reaction Analysis [PDF]

, 1992
Yoshiyuki Nakatsuji, Akihiro Matsumoto, Eiji Tanaka, Hiroyuki Ogata, Kendo Kiyosawa   +4 more
openalex   +1 more source